Eagle Ridge Investment Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,740
| Closed | -$200K | – | 153 |
|
|
2018
Q3 | $200K | Buy |
+4,740
| New | +$200K | 0.03% | 169 |
|
|
2018
Q2 | – | Sell |
-4,988
| Closed | -$248K | – | 171 |
|
|
2018
Q1 | $248K | Buy |
4,988
+248
| +5% | +$12.3K | 0.04% | 152 |
|
|
2017
Q4 | $256K | Buy |
4,740
+400
| +9% | +$21.6K | 0.04% | 155 |
|
|
2017
Q3 | $252K | Hold |
4,340
| – | – | 0.04% | 147 |
|
|
2017
Q2 | $214K | Buy |
+4,340
| New | +$214K | 0.04% | 127 |
|
|
2017
Q1 | – | Sell |
-4,610
| Closed | -$226K | – | 137 |
|
|
2016
Q4 | $226K | Hold |
4,610
| – | – | 0.05% | 133 |
|
|
2016
Q3 | $221K | Hold |
4,610
| – | – | 0.05% | 126 |
|
|
2016
Q2 | $247K | Sell |
4,610
-240
| -5% | -$12.9K | 0.06% | 120 |
|
|
2016
Q1 | $217K | Buy |
+4,850
| New | +$217K | 0.05% | 118 |
|